The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease

Background: Increasing expression of programmed death-1 (PD-1) in patients with nontuberculous mycobacteria lung disease (NTM-LD) has been reported, but its role in clinical characteristics and outcomes remains unclear. Methods: We enrolled 96 participants, including 46 with <i>Mycobacterium a...

Full description

Bibliographic Details
Main Authors: Chin-Chung Shu, Sheng-Wei Pan, Jia-Yih Feng, Jann-Yuan Wang, Yu-Jiun Chan, Chong-Jen Yu, Wei-Juin Su
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/8/5/736
id doaj-f38a232913b9491bae4bc76320f18e27
record_format Article
spelling doaj-f38a232913b9491bae4bc76320f18e272020-11-25T00:52:59ZengMDPI AGJournal of Clinical Medicine2077-03832019-05-018573610.3390/jcm8050736jcm8050736The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung DiseaseChin-Chung Shu0Sheng-Wei Pan1Jia-Yih Feng2Jann-Yuan Wang3Yu-Jiun Chan4Chong-Jen Yu5Wei-Juin Su6Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, TaiwanDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei 112, TaiwanDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei 112, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 100, TaiwanDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei 112, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 100, TaiwanDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei 112, TaiwanBackground: Increasing expression of programmed death-1 (PD-1) in patients with nontuberculous mycobacteria lung disease (NTM-LD) has been reported, but its role in clinical characteristics and outcomes remains unclear. Methods: We enrolled 96 participants, including 46 with <i>Mycobacterium avium</i> complex (MAC)-LD, 23 with <i>M. abscessus</i> (MAB)-LD, and 27 controls. We measured expressions of PD-1, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and regulatory T (Treg) cells on CD4<sup>+</sup> lymphocytes and myeloid-derived suppressor cells (MDSCs) and analyzed their association with clinical features and radiographic outcomes. Results: The percentage of PD-1 on CD4<sup>+</sup>(PD-1<sup>+</sup>CD4<sup>+</sup>) lymphocytes and MDSCs were higher in the MAC-LD group than the controls. There were no intergroup differences regarding CTLA-4<sup>+</sup>CD4<sup>+</sup> lymphocytes. Higher PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes were found in <i>M. intracellulare-</i> and <i>M. avium</i>-LD than in other MAC-LD. Positive sputum acid-fast stains and fibrocavitary radiographic lesions were correlated with elevated PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes and Treg cells. The percentage of PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes at the initial and 2 months of follow-up significantly predicted subsequent radiographic progression. Conclusion: As markers of immune tolerance, PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes and MDSCs were higher in MAC-LD patients. The levels of PD-1<sup>+</sup>CD4<sup>+</sup> and Treg cells were correlated with high mycobacteria bacilli burden in NTM-LD. Monitoring the expressions of PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes may predict radiographic progression.https://www.mdpi.com/2077-0383/8/5/736cytotoxic T-lymphocyte antigen-4<i>Mycobacterium avium</i> complex<i>Mycobacterium abscessus</i>myeloid derived suppressor cellsnontuberculous mycobacteriaprogrammed death-1regulatory T cells
collection DOAJ
language English
format Article
sources DOAJ
author Chin-Chung Shu
Sheng-Wei Pan
Jia-Yih Feng
Jann-Yuan Wang
Yu-Jiun Chan
Chong-Jen Yu
Wei-Juin Su
spellingShingle Chin-Chung Shu
Sheng-Wei Pan
Jia-Yih Feng
Jann-Yuan Wang
Yu-Jiun Chan
Chong-Jen Yu
Wei-Juin Su
The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease
Journal of Clinical Medicine
cytotoxic T-lymphocyte antigen-4
<i>Mycobacterium avium</i> complex
<i>Mycobacterium abscessus</i>
myeloid derived suppressor cells
nontuberculous mycobacteria
programmed death-1
regulatory T cells
author_facet Chin-Chung Shu
Sheng-Wei Pan
Jia-Yih Feng
Jann-Yuan Wang
Yu-Jiun Chan
Chong-Jen Yu
Wei-Juin Su
author_sort Chin-Chung Shu
title The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease
title_short The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease
title_full The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease
title_fullStr The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease
title_full_unstemmed The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease
title_sort clinical significance of programmed death-1, regulatory t cells and myeloid derived suppressor cells in patients with nontuberculous mycobacteria-lung disease
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-05-01
description Background: Increasing expression of programmed death-1 (PD-1) in patients with nontuberculous mycobacteria lung disease (NTM-LD) has been reported, but its role in clinical characteristics and outcomes remains unclear. Methods: We enrolled 96 participants, including 46 with <i>Mycobacterium avium</i> complex (MAC)-LD, 23 with <i>M. abscessus</i> (MAB)-LD, and 27 controls. We measured expressions of PD-1, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and regulatory T (Treg) cells on CD4<sup>+</sup> lymphocytes and myeloid-derived suppressor cells (MDSCs) and analyzed their association with clinical features and radiographic outcomes. Results: The percentage of PD-1 on CD4<sup>+</sup>(PD-1<sup>+</sup>CD4<sup>+</sup>) lymphocytes and MDSCs were higher in the MAC-LD group than the controls. There were no intergroup differences regarding CTLA-4<sup>+</sup>CD4<sup>+</sup> lymphocytes. Higher PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes were found in <i>M. intracellulare-</i> and <i>M. avium</i>-LD than in other MAC-LD. Positive sputum acid-fast stains and fibrocavitary radiographic lesions were correlated with elevated PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes and Treg cells. The percentage of PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes at the initial and 2 months of follow-up significantly predicted subsequent radiographic progression. Conclusion: As markers of immune tolerance, PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes and MDSCs were higher in MAC-LD patients. The levels of PD-1<sup>+</sup>CD4<sup>+</sup> and Treg cells were correlated with high mycobacteria bacilli burden in NTM-LD. Monitoring the expressions of PD-1<sup>+</sup>CD4<sup>+</sup> lymphocytes may predict radiographic progression.
topic cytotoxic T-lymphocyte antigen-4
<i>Mycobacterium avium</i> complex
<i>Mycobacterium abscessus</i>
myeloid derived suppressor cells
nontuberculous mycobacteria
programmed death-1
regulatory T cells
url https://www.mdpi.com/2077-0383/8/5/736
work_keys_str_mv AT chinchungshu theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT shengweipan theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT jiayihfeng theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT jannyuanwang theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT yujiunchan theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT chongjenyu theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT weijuinsu theclinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT chinchungshu clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT shengweipan clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT jiayihfeng clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT jannyuanwang clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT yujiunchan clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT chongjenyu clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
AT weijuinsu clinicalsignificanceofprogrammeddeath1regulatorytcellsandmyeloidderivedsuppressorcellsinpatientswithnontuberculousmycobacterialungdisease
_version_ 1725239864038785024